Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology? (Q38088948)

28 August 2017

title

Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology? (English)

1 reference

28 August 2017

1 reference

Toshio Miyata

1

1 reference

28 August 2017

Norio Suzuki

series ordinal

2

1 reference

28 August 2017

Charles van Ypersele de Strihou

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

13 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

84

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

693-702

1 reference

Oxygen, the lead actor in the pathophysiologic drama: enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Regulation of erythropoietin production

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Repression via the GATA box is essential for tissue-specific erythropoietin gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

The interstitial response to renal injury: Fibroblast–like cells show phenotypic changes and have reduced potential for erythropoietin gene expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Hyperglycemic pseudohypoxia and diabetic complications.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Increased oxidized form of human serum albumin in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Protein-bound acrolein: potential markers for oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Oxidants in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Oxidative stress as a major culprit in kidney disease in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Angiotensin II induces superoxide anion production by mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Transition metals redox: reviving an old plot for diabetic vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

AGE, RAGE, and ROS in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

New era for drug discovery and development in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Hypoxia-inducible factors and tubular cell survival in isolated perfused kidneys

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Hypoxia in renal disease with proteinuria and/or glomerular hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Pathogenesis of renal anemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Erythropoietin and renoprotection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Diabetic nephropathy: a disorder of oxygen metabolism?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Endoplasmic reticulum stress: cell life and death decisions.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Proteinuria and hyperglycemia induce endoplasmic reticulum stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Anemia of chronic renal failure: characterization in the mouse and correction with human recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Cardio-renal-anemia syndrome: a link between erythropoietin, dimethylarginine and homocysteine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Use of gene-manipulated mice in the study of erythropoietin gene expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Survival and proliferative roles of erythropoietin beyond the erythroid lineage

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Targeting HIF-1 for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Cell biology. How cells endure low oxygen

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Oxygen sensing by HIF hydroxylases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

A nuclear localization signal of human aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor 1beta is a novel bipartite type recognized by the two components of nuclear pore-targeting complex

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

A gain-of-function mutation in the HIF2A gene in familial erythrocytosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Involvement of hypoxia-inducible transcription factors in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Presence of Cobalt in the Anti-Pernicious Anæmia Factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Erythropoietic effect of cobalt in patients with or without anemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Cellular oxygen sensing: Importins and exportins are mediators of intracellular localisation of prolyl-4-hydroxylases PHD1 and PHD2.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Nuclear oxygen sensing: induction of endogenous prolyl-hydroxylase 2 activity by hypoxia and nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Role and regulation of prolyl hydroxylase domain proteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Regulatory mechanisms controlling gene expression mediated by the antioxidant response element

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Role of NRF2 in protection against hyperoxic lung injury in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

The transcription factor NRF2 protects against pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Hypoxia. 1. Intracellular sensors for oxygen and oxidative stress: novel therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Isolation and characterization of renal erythropoietin-producing cells from genetically produced anemia mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Identification of the renal erythropoietin-producing cells using transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Fibroblast expression of an IκB dominant-negative transgene attenuates renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Selective inhibition of factor inhibiting hypoxia-inducible factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

PHD2 mutation and congenital erythrocytosis with paraganglioma.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Hibernation, a model of neuroprotection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Hypoxia tolerance in mammalian heterotherms.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Inositol tripyrophosphate: a new membrane permeant allosteric effector of haemoglobin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Control of Hemoglobin Function within the Red Cell

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Importance of oxygen-haemoglobin binding to oxygen transport in congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Long-term physiological effects of enhanced O2 release by inositol hexaphosphate-loaded erythrocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Myo-InositolTrisPyroPhosphate treatment leads to HIF-1α suppression and eradication of early hepatoma tumors in rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

NXY-059 for the treatment of acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Effects of NXY-059 in experimental stroke: an individual animal meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Nrf2-deficient female mice develop lupus-like autoimmune nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Bardoxolone methyl and kidney function in CKD with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Specific contribution of the erythropoietin gene 3' enhancer to hepatic erythropoiesis after late embryonic stages

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Reactivation of hepatic EPO synthesis in mice after PHD loss

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.74

7 January 2021

Identifiers

DOI

10.1038/KI.2013.74

1 reference

Dimensions Publication ID

28 August 2017

1006143465

0 references

1 reference